April 24, 2024

• 

[THE INVESTOR] As of Sept. 19 10:10 A.M., Samjin Pharmaceutical declined 1.5%, compared with yesterday, to 32,800 won. It had edged along with a similar price through the past month. Standard deviation, the volatility index for stock price, was 1.4% on the same period of time over one month.

Compared with its close competitors within the same industry, KOSPI, as the monthly volatility of Samjin Pharmaceutical was the lowest, the investment return for 1 month was also at the lowest level among its peer group. Over the recent month, the return-on-risk, the return on investment with consideration about risk, was 0.1%. Even though the volatility was not so high, the return-on-risk was the lowest through a decline in investment returns. Moreover, compared with the KOSPI industry, the return-on-risk is below the industrial mean, 5.2, and thus the industrial comparison performance was not so good.

By HeRo (hero@heraldcorp.com)
This article is produced by the algorithm developed by the artificial intelligence developer ThinkPool in collaboration with Herald Corp